Opportunities for laboratory diagnosis of myocardial damage in COVID-19: focus on chronic heart failure

Abstract

Recent studies of patients with COVID-19 have shown that people with cardiovascular disease, hypertension, bleeding disorders, and diabetes have severe symptoms and higher mortality rates. In addition to cardiovascular disease, potential risks also include age, gender, immunosuppressive state, multiple organ dysfunction, chronic respiratory disease, kidney dysfunction, obesity, and cancer. In the practice of a doctor, it is important to be able to predict and prevent the development of complications, so it is necessary to identify the relationship between COVID-19 and cardiovascular diseases at the molecular level. These data will help in the development of markers for the development of complications and provide an opportunity to adjust treatment tactics and prevent their occurrence. This review considers changes in the main markers of heart failure in coronavirus infection, which can be used for risk stratification.

Keywords

• chronic heart failure
• covid-19
• markers of heart failure
• inflammation
• myocardial damage.